Previous close | 1.5700 |
Open | 1.5800 |
Bid | 1.5100 x 100 |
Ask | 1.6000 x 100 |
Day's range | 1.5200 - 1.6300 |
52-week range | 0.6220 - 2.5000 |
Volume | |
Avg. volume | 203,880 |
Market cap | 25.66M |
Beta (5Y monthly) | 2.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02. ITRM isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to the […]
Q4 2023 Iterum Therapeutics PLC Earnings Call
Iterum (ITRM) stock rises as the company gears up to submit a regulatory application to the FDA seeking approval for oral sulopenem to treat adult women with uUTIs ahead of schedule.